A novel capecitabine schedule (7 on—7 off) is feasible with lapatinib for patients with HER2-positive metastatic breast cancer refractory to trastuzumab Meeting Abstract
| Authors: | Gajria, D.; Theodoulou, M.; Feigin, K.; Patil, S.; Geneus, S.; Drullinsky, P.; D'Andrea, G.; Lake, D.; Norton, L.; Hudis, C.; Traina, T. A. |
| Abstract Title: | A novel capecitabine schedule (7 on—7 off) is feasible with lapatinib for patients with HER2-positive metastatic breast cancer refractory to trastuzumab |
| Meeting Title: | 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 70 |
| Issue: | 24 Suppl. |
| Meeting Dates: | 2010 Dec 9-12 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2010-12-15 |
| Language: | English |
| ACCESSION: | WOS:000209695800289 |
| DOI: | 10.1158/0008-5472.sabcs10-p6-11-12 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P6-11-12 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work